Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular fluid (ECF) volume expansion refers to an increase in the volume of fluid present outside the body’s cells. It primarily results from increased total body sodium content leading to water retention. Conditions such as heart failure, kidney failure, and cirrhosis are common causes. Clinical manifestations include edema, hypertension, and ascites. Management involves removing excess fluid using diuretics or other methods, while monitoring electrolyte balance and renal function.
Diuretics promote fluid excretion; vasopressin antagonists reduce water retention; RAAS inhibitors reduce sodium and water retention.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular Fluid Volume Expansion (None).